AYTU BIOPHARMA, INC Public Float
AYTU BIOPHARMA, INC (AYTU) had Public Float of $23.97 million as of 2025-12-31, per its 10-K filed 2026-09-22.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-09-22
- 2025-12-31: Entity Public Float $23.97M.
- 2024-12-31: Entity Public Float $7.24M.
- 2023-12-29: Entity Public Float $10.71M.
- 2022-12-30: Entity Public Float $12.30M.
| Period end | Entity Public Float |
|---|---|
| 2025-12-31 | $23.97M 10-K · filed 2026-09-22 |
| 2024-12-31 | $7.24M 10-K · filed 2025-09-23 |
| 2023-12-29 | $10.71M 10-K · filed 2024-09-26 |
| 2022-12-30 | $12.30M 10-K · filed 2023-10-12 |
| 2021-12-31 | $38.20M 10-K · filed 2022-09-27 |
| 2020-12-31 | $88.40M 10-K/A · filed 2022-02-22 |
| 2019-12-31 | $10.10M 10-K · filed 2020-10-06 |
| 2018-12-31 | $6.90M 10-K · filed 2019-09-26 |
| 2017-12-31 | $7.90M 10-K · filed 2018-09-06 |
| 2016-12-31 | $10.50M 10-K · filed 2017-08-31 |
| 2015-12-31 | $9.90M 10-K · filed 2016-09-01 |
| 2014-12-31 | $4.35M 10-K · filed 2015-09-28 |
| 2013-11-26 | $1.10M 10-K · filed 2014-11-26 |
| 2012-11-20 | $3.12M 10-K · filed 2012-11-29 |
| 2011-12-23 | $1.06M 10-Q · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |